PT  - JOURNAL ARTICLE
AU  - Zhu, Yenan
AU  - Lin, Yueh-Yun
AU  - Li, Ruosha
AU  - He, Cara
AU  - Lairson, David R.
AU  - Deshmukh, Ashish A.
AU  - Sonawane, Kalyani
TI  - Reimbursement for HPV Vaccine Cost in the Private Sector: A Comparison Across Specialties
AID  - 10.1370/afm.2990
DP  - 2023 Jul 01
TA  - The Annals of Family Medicine
PG  - 344--346
VI  - 21
IP  - 4
4099  - http://www.annfammed.org/content/21/4/344.short
4100  - http://www.annfammed.org/content/21/4/344.full
SO  - Ann Fam Med2023 Jul 01; 21
AB  - The human papillomavirus (HPV) vaccine is the most expensive of all routinely recommended pediatric vaccines. Adequate cost reimbursement by 3rd-party payers is a critical enabling factor for clinicians to continue offering vaccines. This study found that net returns from HPV vaccine cost reimbursements are lowest for family physicians ($0.34/dose) and highest for pediatricians ($5.08/dose). Furthermore, a $1 increment in return was associated with an increase in HPV vaccine doses administered (highest for family physicians; 0.08% per dollar). Reimbursement for HPV vaccine costs by private payers is adequate; however, return margins are small for non-pediatric specialties.